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Thymic epithelial cells (TECs) provide the microenvironment required for the development
of T cells in the thymus. A unique property of medullary thymic epithelial cells (mTECs)
is their expression of a wide range of tissue-restricted self-antigens, critically regulated
by the nuclear protein AIRE, which contributes to the selection of the self-tolerant T cell
repertoire, thereby suppressing the onset of autoimmune diseases. The TNF receptor
family (TNFRF) protein receptor activator of NF-κB (RANK), CD40 and lymphotoxin β
receptor (LtβR) regulate the development and functions of mTECs. The engagement of
these receptors with their specific ligands results in the activation of the NF-κB family
of transcription factors. Two NF-κB activation pathways, the classical and non-classical
pathways, promote the development of mature mTECs induced by these receptors.
Consistently, TNF receptor-associated factor (TRAF6), the signal transducer of the classical
pathway, and NF-κB inducing kinase (NIK), the signal transducer of the non-classical
pathway, are essential for the development of mature mTECs. This review summarizes
the current understanding of how the signaling by the TNF receptor family controls the
development and functions of mTEC.
Keywords: medullary thymic epithelial cells, TNF receptor family, NF-κB, signal transduction, self-tolerance,
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INTRODUCTION
The development of self-tolerant T cells and regulatory T cells
in the thymus requires a microenvironment of both non-
hematopoietic stroma cells and cells of hematopoietic origin
(Gill et al., 2003; Takahama, 2006; Anderson and Takahama,
2012). Thymic epithelial cells (TECs), essential components of
this unique microenvironment, are subdivided into two major
subtypes according to their localization:medullary thymic epithe-
lial cells (mTECs) and cortical thymic epithelial cells (cTECs).
IL-7 and Delta-like 4 expressed by TECs promote their prolifer-
ation and commitment to the T-cell lineage, thereby leading to
the differentiation of CD4+CD8+ double-positive (DP) T cells
expressing a diverse repertoire of T-cell antigen receptors (TCRs)
(Hozumi et al., 2008; Koch et al., 2008; Hong et al., 2012).
Subsequently, this T-cell repertoire is scrutinized by the TECs
displaying the complex of self-peptides and MHC molecules
(self-pMHCs) (Kyewski and Klein, 2006; Anderson et al., 2007;
Klein et al., 2009). The presentation of self-pMHCs by cTECs is
required for the survival and differentiation of DP cells to CD4-
or CD8-single-positive (CD4SP or CD8SP) T cells. This process,
positive selection, is achieved when a TCR binds to a self-pMHC
with moderate avidity, whereas T cells expressing a TCR recogniz-
ing a self-pMHC with high avidity undergo apoptosis, i.e., nega-
tive selection. Several studies suggest that mTECs are involved in
negative selection, thereby preventing the onset of autoimmune
diseases (Mathis and Benoist, 2004; Kyewski and Klein, 2006;
Anderson et al., 2007; Klein et al., 2009). Moreover, mTECsmight
contribute to the development of thymic regulatory T cells (Tregs)
expressing the transcription factor Foxp3 (Hsieh et al., 2012),
which suppress autoimmune responses and excessive immune
reactions (Wing and Sakaguchi, 2010; Josefowicz et al., 2012).
Given the connections with autoimmune diseases, researchers
have been striving to uncover the molecular mechanisms under-
lying the functions and development of mTECs. In this review,
we primarily focus on the role of signaling by the TNF recep-
tor family (TNFRF) members RANK, CD40, and LtβR in the
development and functions of mTECs in the establishment of
self-tolerance.
FUNCTIONS OF mTECs
It is well established that mTECs ectopically express a wide
variety of self-antigens that are normally expressed in a tissue-
specific fashion (TSAs, for example, insulin, c-reactive protein,
and caseins) (Kyewski and Klein, 2006). Because mature mTECs
express high levels of MHC class II, co-stimulatory molecule
CD80 and antigen-processing enzymes (Gray et al., 2006; Guerder
et al., 2012), it is likely that mTECs directly perform negative
selection by presenting TSA-peptides, as was confirmed in a
recent study (Hinterberger et al., 2010) (Figure 1). Additionally,
the TSAs expressed in mTECs are transferred to and presented
by cDCs for negative selection (Gallegos and Bevan, 2004; Koble
and Kyewski, 2009) (Figure 1). Consequently, the T cells that are
potentially reactive to the TSAs in the periphery would undergo
apoptosis in the thymus. It is important future study to clar-
ify the relative contributions of mTECs and cDCs to negative
selection.
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FIGURE 1 | The hypothetical model for the development and functions of
mTECs and molecules to promote themTEC development. Bipotent
common progenitors give rise to the mTEC progenitors expressing claudin-3
and -4.Lymphoid tissue inducer (LTi), Vγ5+DETCprogenitor (Vγ5+) orpositively
selected α β T cells produce RANKL; CD40L is supplied only by α β T cells. The
interaction between RANKL and RANK promotes the differentiation and/or
proliferation of the mTECs. The similar contribution of the interaction of CD40L
and CD40 begins at the neonatal stage. RANK and CD40 signaling results in the
translocation of the NF-κB family member RelB through the activation of signal
transducers TRAF6 and NIK. Themature mTECs express a wide variety of
tissue-specific antigens (TSAs) and AIRE. The TSAs are in part transferred to
conventional DCs; as a result, both the mTECs and DCs would display the
TSA-peptides to the developing T cells. The T cells expressing TCR bound to
the complex of the TSA-peptide and MHCmolecules with high avidity undergo
apoptosis.Mature mTECsmight further differentiate into involucrin-expressing
mTECs in the LtβR and AIRE-dependent process. The LtβR signaling might
regulate the up-regulation of RANK in the TECs and/or enhance the proliferation
of the RANK-expressing TECs. Ligands and receptors involved in each process
are surrounded by red line rectangles, signal transducers are by green line
rectangles, transcription factors are by blue line rectangles.
Autoimmune regulator (AIRE), for which loss of function
mutations cause an inherited human autoimmune disease
(Consortium, 1997; Nagamine et al., 1997; Michels and Gottlieb,
2010), is expressed in mTECs and promotes TSA expression,
thereby suppressing the onset of autoimmune diseases (Anderson
et al., 2002; Peterson et al., 2008; Mathis and Benoist, 2009).
Although the involvement of AIRE is evident, the molecular
mechanisms underlying a broad range of TSA expression in
mTECs remain unclear. The unique epigenetic regulation in
mature mTECs appears to regulate the diversity of TSA expres-
sion (Derbinski et al., 2005; Tykocinski et al., 2010). Interestingly,
individual mTECs appear to have a different and transient
TSA expression pattern, implying the probabilistic nature of the
expression of TSAs (Derbinski et al., 2008; Villaseñor et al.,
2008).
The requirement of TSA expression in preventing the onset
of autoimmune diseases was suggested by the results of sev-
eral studies (Kyewski and Klein, 2006). It was reported that the
polymorphisms in the promoter region of the muscle acetyl-
choline receptor gene (CHRNA1), which is associated with the
early onset of human autoimmune myasthenia gravis, leads to
the reduction of CHRNA1 expression in human mTECs (Giraud
et al., 2007). Two studies provide more direct evidence for
the correlation between the expression of TSAs in mTECs and
autoimmunity in the corresponding tissues. The lack of inter-
photoreceptor retinoid-binding protein in thymic stroma cells
is sufficient for inducing spontaneous autoimmunity in the
eyes (DeVoss et al., 2006). Moreover, deletions of insulins in
AIRE-expressing mTECs spontaneously provoked autoimmune
diabetes in mice (Fan et al., 2009).
The high avidity interaction between TCRs and self-pMHCs is
the determinant of the development of Treg (Hsieh et al., 2012;
Josefowicz et al., 2012). Previous studies revealed that the cTEC-
specific expression of MHC class II (MHC II) is sufficient for
Treg generation in the thymus (Bensinger et al., 2001). Moreover,
a recent study revealed that the diversity of TCRs in Tregs was
not altered by the lack of AIRE (Daniely et al., 2010). These
data suggest that TSA presentation by mTECs is dispensable for
thymic Treg development. However, almost all Foxp3+ cells in
the thymus are CD4SP T cells localized in the medulla (Lee and
Hsieh, 2009), and Foxp3+ expression initiates at the stage of the
CD4SP progenitor (Burchill et al., 2008; Lio and Hsieh, 2008).
Thus, the contribution of mTECs to Treg differentiation and/or
proliferation cannot be ruled out (Hsieh et al., 2012). Indeed,
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several mTEC-deficient mice showed a partial reduction in the
Treg frequency in the thymus (Kajiura et al., 2004; Shimo et al.,
2011).
The chemokines CCL19 and CCL21 secreted from mTECs
attract positively selected T cells expressing the chemokine recep-
tor CCR7 into the medulla (Ueno et al., 2002, 2004). A recent
study revealed that mTECs also express the chemokine XCL to
attract cDCs in the medulla (Lei et al., 2011). Interestingly, the
expression of CCL19, CCL21, and XCL appear to be regulated by
AIRE (Laan et al., 2009; Lei et al., 2011). These findings might be
consistent with the idea that AIRE regulates the differentiation of
mTECs as well as the TSA expression (Gillard et al., 2007; Dooley
et al., 2008; Yano et al., 2008).
DEVELOPMENT OF mTECs
The endodermal epithelial cells in the ventral part of third pha-
ryngeal pouch differentiate into TECs (Blackburn and Manley,
2004; Holländer et al., 2006). Then, both the mTECs and cTECs
are differentiated from bipotent TEC progenitors (Bleul et al.,
2006; Rossi et al., 2006). The existence of mTEC-committed
progenitors was initially proposed from the finding that the
mTECs form clusters expressing a single MHC II in the thy-
muses of chimeric mice with two different types of MHC II
molecules (Rodewald et al., 2001). Furthermore, it was shown
that the TEC fraction expressing claudin-3 and -4, components
of tight junction, differentiates into AIRE+ mTECs but not
into cTECs (Hamazaki et al., 2007). Another study suggested
that CD80− UEA-1-lectin+ TECs emerging in embryonic thy-
mus contain the mTEC progenitors (Gäbler et al., 2007). The
rapid turnover of mTECs (Gray et al., 2006, 2007) and post-
mitotic nature of the AIRE-expressing cells (Gray et al., 2007)
in the adult thymus imply the presence of progenitors that
continuously provide mature mTECs. Indeed, the CD80− UEA-
1+ TECs prepared from postnatal thymuses are converted into
CD80+ UEA-1+ mTECs in re-aggregated fetal thymus organ
cultures (Gäbler et al., 2007). Currently, the ratio of mTEC pro-
genitors in the claudin-3/4+ CD80− UEA-1+ TEC fraction is
unclear, and it remains elusive whether the mTEC progenitors
in the adult thymus are identical to those in the embryonic
thymus.
In the adult thymus, the mTECs are separated into mainly
two subsets (Gray et al., 2006). The first subset expresses rel-
atively higher levels of MHC II and CD80, usually referred to
as mTEChigh; this subset contains AIRE-expressing cells and is
regarded as the mature type (Kyewski and Klein, 2006). The other
subset, mTEClow, shows relatively lower expression levels of MHC
II and CD80. The mTEChigh subset would be expected to play a
role in negative selection because of the expression of AIRE, the
wide range of TSAs as well as their high antigen-presenting ability,
whereas the contribution of the mTEClow subset on thymic toler-
ance remains to be addressed. In addition to these two subsets,
the mTECs expressing involucrin, a keratinocyte terminal differ-
entiationmarker, are regarded as terminally differentiated mTECs
(Yano et al., 2008;White et al., 2010). Moreover, a recent fatemap-
ping of AIRE expression suggested another developmental stage
of mTECs in which the expression of AIRE ceases (Nishikawa
et al., 2010).
TNF RECEPTOR FAMILY SIGNALING
The binding of TNF family ligands to the TNFRF proteins leads
to various cellular responses, such as proliferation, differentia-
tion, inflammatory responses, and apoptosis (Aggarwal, 2003;
Hehlgans and Pfeffer, 2005; Aggarwal et al., 2012). Several mem-
bers of the TNFRF activate NF-κB family transcription factors,
inducing the expression of the genes required for these cel-
lular responses (Aggarwal, 2003; Hehlgans and Pfeffer, 2005;
Vallabhapurapu and Karin, 2009). Several lines of evidence have
indicated that the signaling of the TNFRF members RANK,
CD40, and LtβR play critical roles in the development and func-
tion of mTECs.
CD40L-CD40
The engagement of CD40 with CD40L initiates and progresses
acquired immune responses through the activation and survival
of B cells, macrophages, and DCs (Elgueta et al., 2009; Ma and
Clark, 2009). The expression of CD40 in human TECs was ini-
tially reported almost two decades ago (Galy and Spits, 1992),
and, because the CD40 signal exerts profound effects on antigen
presenting cells, several studies on the function of CD40 in the
thymus have focused on the roles in proliferation and the selec-
tion of T cells (Foy et al., 1995; Ruggiero et al., 1996; Williams
et al., 2002) and Treg development (Kumanogoh et al., 2001;
Spence and Green, 2008; Martín-Gayo et al., 2010).
Several studies have provided evidence that CD40 signaling
controls the development of mTECs. The forced expression of
CD40L by the lck promoter caused a reduction of the cTECs
and an increase of mTECs (Dunn et al., 1997), and both CD40L-
deficient (CD40L-KO) mice and CD40-KOmice showed a reduc-
tion of mTECs (Gray et al., 2006; Akiyama et al., 2008; White
et al., 2008). In addition, the in vitro development of mTECs is
elicited by the addition of recombinant CD40L protein to fetal
thymic stroma organ culture (Akiyama et al., 2008), which is pre-
pared from fetal thymus by the elimination of cells of hematopoi-
etic origin. Notably, whereas CD40 is expressed in the TECs of
fetal thymus (Dunn et al., 1997; Akiyama et al., 2008; Shakib et al.,
2009), the expression of CD40L was not detected in the fetal thy-
mus but only began in the neonatal mouse (Dunn et al., 1997;
Akiyama et al., 2005). This expression pattern suggested that the
contribution of the CD40L-CD40 interaction to the development
of mTECs should be limited following birth. The expression of
CD40L in the thymus was predominantly detected in the medulla
(Dunn et al., 1997). Consistently, some studies indicated that the
expression of CD40L is up-regulated in positively selected CD4SP
T cells (Hikosaka et al., 2008; Irla et al., 2008).
RANKL-RANK
The RANKL and RANK interaction regulates a diverse set of
physiological events, such as bone homeostasis (Yasuda et al.,
1998; Dougall et al., 1999; Kong et al., 1999), lymph node
development (Kong et al., 1999; Kim et al., 2000), mammary
gland development (Fata et al., 2000), hair follicle anagen
(Duheron et al., 2011), and DC survival (Anderson et al., 1997;
Wong et al., 1997). RANKL-deficient (RANKL-KO) and RANK-
deficient (RANK-KO) mice exhibited a reduction in mature
mTECs (Rossi et al., 2007; Akiyama et al., 2008; Hikosaka
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et al., 2008), which was more remarkable for the mTEChigh sub-
set. Moreover, recombinant RANKL protein efficiently induces
the development of mTECs expressing AIRE and TSAs in fetal
thymic stroma culture (Rossi et al., 2007; Akiyama et al., 2008).
Although a lack of the RANKL-RANK interaction causes a sig-
nificant reduction of mature mTECs, a small population of
mature mTECs still exists in these mutant mice (Akiyama et al.,
2008; Hikosaka et al., 2008), a finding that suggests the pres-
ence of another signal for inducing mature mTECs in addition to
RANK signaling. Indeed, mature mTECs were completely absent
in RANKL- and CD40-double deficient (RANKL/CD40 DKO)
mice (Akiyama et al., 2008). Thus, RANK and CD40 signal-
ing have an overlapping function in the development of mature
mTECs. Osteoprotegerin, OPG, a natural inhibitor of RANKL,
is expressed in mTECs (Hikosaka et al., 2008), and, consistently,
OPG-deficient mice showed an increase in mTECs in the thymus
(Hikosaka et al., 2008).
RANKL is produced by certain types of thymic cells. An ini-
tial study revealed that lymphoid tissue inducer cells (LTi) express
RANKL in the fetal thymus (Rossi et al., 2007). Furthermore, a
recent study uncovered the role of the progenitors of Vγ 5 chain-
positive dendritic epidermal T cells (DETC), a subset of γ δ T
cells, in supplying RANKL in the embryonic thymus (Roberts
et al., 2012). Interestingly, the RANKL signal in turn induces the
expression of Skint-1 in mTECs, promoting the selection and
generation of the monoclonal DETC compartment (Barbee et al.,
2011), which suggests a role for the mTECs in DETC selection. In
addition, RANKL is provided by positively selected α β T cells in
adult thymus (Hikosaka et al., 2008).
As described above, because the CD40L expression is practi-
cally absent in the fetal thymus, RANKL is essential for themature
mTEC development in embryo (Akiyama et al., 2008). Currently,
the relative contributions of LTi and Vγ 5+ thymocytes to the
RANKL expression remain to be determined. Moreover, other
lymphoid cells might be involved in the expression of RANKL in
the fetal thymus because small numbers of AIRE+ mTECs were
present in the mice lacking both LTi and Vγ 5+ thymocytes. In
the postnatal thymus, large numbers of α β T cells supply both
RANKL and CD40L. Therefore, contributions of LTi and Vγ 5+
thymocytes might be limited due to their low frequency.
RANKL KO and RANK KO mice did not show any appre-
ciable autoimmune phenotypes, which may be because a small
amount of AIRE and low number of mature mTECs are suffi-
cient for suppressing autoimmunity. Another possibility is that
the interaction of RANKL and RANK in other immune cells
is required for the progression of autoimmunity in peripheral
organs. Consistent with the latter possibility, a transplantation of
RANK-KO fetal thymic stroma (Rossi et al., 2007) or an adop-
tive transfer of splenocytes from RANKL-KO or RANKL/CD40
DKO mice (Akiyama et al., 2008) provoked autoimmunity in the
recipient nude mice.
LYMPHOTOXIN β RECEPTOR
LtβR is essential for the organogenesis of secondary lymphoid
organs (Mebius, 2003; Drayton et al., 2006; Randall et al., 2008).
There are at least two types of ligands that bind to LtβR: a het-
erotrimer consisting of Ltα and Ltβ and the Light homotrimer.
Although LtβR-deficient mice show a defect in the development
of mTECs (Boehm et al., 2003; Venanzi et al., 2007), the devel-
opmental processes regulated by LtβR signaling remain unclear
(Zhu et al., 2010). The injection of an agonistic LtβR antibody
into mice increases the expression of AIRE within a few hours
(Chin et al., 2003), and the treatment of an mTEC line with the
same antibody induces the expression of AIRE in the presence of
a DNA methylation inhibitor (Chin et al., 2003). However, the
expression levels of AIRE in the mTECs isolated from LtβR-KO
mice are comparable to wild-type mice (Venanzi et al., 2007),
and the treatment of fetal thymic stroma with an agonistic LtβR
antibody failed to induce the expression of AIRE (Akiyama et al.,
2008). Thus, a direct linkage between LtβR signaling and AIRE
expression seems to be unwarranted. It is probable that the LtβR
signal controls the development of mTECs by a process i.e.,
different from that mediated by the RANK and CD40 signals,
which are more directly linked to the development of mature
AIRE-expressing mTECs. Indeed, LtβR is involved in the expres-
sion of AIRE-independent TSAs and chemokines in the thymus
(Chin et al., 2006; Zhu et al., 2007; Seach et al., 2008), and a
recent study revealed the requirement of LtβR in the development
of involucrin-expressing mTECs (White et al., 2010). In addi-
tion, another recent study revealed that LtβR signaling induces
the expression of RANK, in turn facilitating the development of
the mature mTECs (Mouri et al., 2011). These mutually non-
exclusive studies suggest that LtβR signaling has multiple roles in
the development and functions of mTECs.
LtβR-KO mice exhibit inflammatory cellular infiltration in
their peripheral organs (Chin et al., 2006). The fetal thymic
stroma transplantation confirmed the requirement of LtβR sig-
naling in the thymic stroma cells for the suppression of autoim-
munity (Chin et al., 2006). In addition, the LtβR signal regulates
the expression of the chemokines that attract lymphocytes in the
medulla (Zhu et al., 2007; Seach et al., 2008). Because the fail-
ure in the movement of the positively selected T cells to the
medulla results in autoimmunity (Kurobe et al., 2006), this func-
tion may be linked to the autoimmune phenotypes observed in
LtβR-KO mice.
INTRACELLULAR SIGNAL TRANSDUCERS AND NF-κB
RANK, CD40, and LtβR signaling activates two distinct NF-κB
activation pathways: the classical and non-classical NF-κB path-
ways (Hayden and Ghosh, 2008; Vallabhapurapu and Karin,
2009) (Figure 2). In the classical pathway, the engagement of
the receptor recruits the TRAF proteins to induce the activa-
tion of the downstream serine threonine kinases (e.g., TGF-β
activating kinase 1), which in turn activate the IKK complex
comprising IKK α, IKK β, and NEMO. Subsequently, the IKK
complex phosphorylates IkBα, sequestering NF-κB in the cyto-
plasm. The phosphorylation of IkBα triggers its degradation by
the ubiquitin-dependent 26S-proteasome complex, which in turn
results in the translocation of the NF-κB family RelA complex
to the nucleus for transcriptional activation. Conversely, in the
non-classical pathway, the engagement of the receptors induces
the release of NIK from the protein complex comprising cIAP1/2,
TRAF2, and TRAF3, a complex that degrades NIK in an unstim-
ulated state. The released NIK phosphorylates IKK α, which in
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FIGURE 2 | The twoNF-κB activationpathways inducedby RANK,CD40,
andLtβRsignaling.EitherRANK,CD40,orLtβRsignaling iscapableofactivating
the non-classical NF-κBpathway. In the steady state, the protein complex
consisting of TRAF2, TRAF3, and cIAP1/2 binds to and poly-ubiquitinatesNF-κB
inducingkinase (NIK). Thepoly-ubiquitinatedNIK is immediatelydegradedby the
26S-proteasomemachinery. Theengagementof the receptorswith their ligands
recruits the TRAF2, TRAF3, and cIAP1/2 complex, leading to the release of NIK
from the complex. The stabilized NIK activates the IKK α complex by
phosphorylation,which in turn phosphorylatesp100, thus sequesteringRelB in
the cytoplasm.Subsequently, p100 ispoly-ubiquitinatedand converted top52by
partial degradation, an event that leads to the nuclear translocation of the active
RelB/p52 complex. TheRANKL-RANKandCD40L-CD40 interaction recruits
TRAF6 to their cytoplasmic tails. TRAF6 activates the downstream
serine/threoninekinase, typically TGF-β activating kinase 1 (TAK1), and activated
TAK1 causes the activation of the IKK complex,which consists of IKK α, IKKβ,
andNEMO.Thereafter, the activated IKKcomplexphosphorylates IkBα, thereby
inducing the degradationof IkBα to lead to the nuclear translocation of theRelA
complex. TheTRAF6-mediatedNF-κB activationmight induce the expressionof
RelB. AlthoughLtβR also can activate the classical pathway, there is no
supportingevidence to date that theLtβR-mediatedclassical pathway regulates
mTECdevelopment.Such proteinmodificationsas phosphorylation and
ubiquitination are omitted in this figure for simplicity.
turn phosphorylates the p100 that sequesters the NF-κB family
member RelB in the cytoplasm. The phosphorylation of p100
triggers its partial degradation to p52, leading to the nuclear
translocation of the RelB/p52 complex to induce gene expression.
RelB-deficient (RelB-KO) mice (Burkly et al., 1995; Weih
et al., 1995; Zuklys et al., 2000) and aly/aly mice (Miyawaki
et al., 1994; Kajiura et al., 2004; Shinzawa et al., 2011), which
have a dysfunctional point mutation in the gene encoding NIK,
showed severe defects in the development of mTECs expressing
AIRE and TSAs. Consistently, these mutant mice exhibit autoim-
mune phenotypes. Although IKKα-deficient (IKK α-KO) mice
die immediately following birth, a defect in mTEC development
was still identified (Kinoshita et al., 2006; Lomada et al., 2007).
Furthermore, p100 (also named NF-κB2)-deficient (p100-KO)
mice showed a partial reduction of the mTEC developmental and
autoimmune phenotypes (Zhang et al., 2006; Zhu et al., 2006).
Therefore, these data strongly suggested that the non-classical
NF-κB pathway is essential for the development of mTECs and
mTEC-mediated self-tolerance. Interestingly, whereas the defect
in mTEC development is mild in the p100-KO mice, p100
and p105 (also named NF-κB1)-double-deficient mice (Franzoso
et al., 1997) and p100 and Bcl-3-double-deficient mice (Zhang
et al., 2007) exhibited more severe defects in the development
of mTEC compared to each single mutant, suggesting redun-
dant roles among these NF-κB members and the nuclear IκB.
Because the non-classical NF-κB pathway can be activated by
either RANK, CD40, or LtβR signaling, the developmental stages
at which these molecules control mTEC development need to be
clarified.
TRAF6, an E3-ubiquitin ligase, activates the classical NF-κB
pathway (Inoue et al., 2007), which indirectly facilitates the non-
classical NF-κB activation pathway by inducing RelB (Bren et al.,
2001; Akiyama et al., 2005) and p100 (Dejardin et al., 2002).
Several studies indicated that TRAF6 mediates RANK signal-
ing (Darnay et al., 2007) and CD40 signaling (Bishop et al.,
2007) but not LtβR signaling (Qin et al., 2007). Consistently,
TRAF6-deficient mice showed a severe defect in mTEC devel-
opment that was comparable to RANKL and CD40 DKO mice
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(Akiyama et al., 2005, 2008). Thus, it is likely that, as a down-
stream molecule of RANK and CD40 signals, TRAF6 is required
for the development of mature mTECs expressing AIRE, TSAs,
and RelB (Akiyama et al., 2005, 2008).
CONCLUDING REMARKS
It is now widely accepted that, despite of the very low frequency
in the population of total thymic cells, mTECs play critical roles
in preventing autoimmunity in the body. Several studies have
provided evidence that RANK, CD40, and LtβR signaling are crit-
ical for the development of mTECs. It is most likely that the
engagement of these receptors activates the two NF-κB activation
pathways. The ensuing transcriptional activation of the NF-κBs
induces the genes that promote the development and function
of mTECs. However, literature on the downstream target genes
induced by these signals in mTECs is currently scarce (Ohshima
et al., 2011), and the identification of these targets is important
for future research because these target genes would define the
unique properties of mTECs. Moreover, the developmental stages
of the mTECs receiving this signaling are not fully characterized,
and the mechanisms and signals that determine the commit-
ment to the mTEC lineage also remain to be addressed. Future
studies, on the biology of mTECs would be informative for the
understanding of the mechanism involved in the establishment
of self-tolerance and the development of the thymic medullary
environment.
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